| Product Code: ETC7628044 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to rely on major exporters like the USA, UK, Germany, Metropolitan France, and Serbia for its DNA and gene chip imports. Despite the high Herfindahl-Hirschman Index (HHI) indicating market concentration, the industry experienced a negative compound annual growth rate (CAGR) of -4.18% from 2020 to 2024. The growth rate plummeted by -30.16% from 2023 to 2024, reflecting potential challenges or shifts in the market dynamics for DNA and gene chip imports in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Industry Life Cycle |
3.4 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Porter's Five Forces |
3.5 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.7 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine in Ireland |
4.2.2 Growing demand for genetic testing and diagnostics |
4.2.3 Technological advancements in DNA sequencing and microarray technology |
4.3 Market Restraints |
4.3.1 High costs associated with DNA and gene chip technology |
4.3.2 Limited awareness and understanding of genetic testing among the general population |
5 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Trends |
6 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Types |
6.1 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Consumables, 2022 - 2032F |
6.1.4 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Instrumentation, 2022 - 2032F |
6.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Oligonucleotide DNA Microarrays (oDNA), 2022 - 2032F |
6.2.3 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Complementary DNA Microarrays (cDNA), 2022 - 2032F |
6.3 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Gene Expression, 2022 - 2032F |
6.3.3 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Cancer Diagnosticsand Treatments, 2022 - 2032F |
6.3.4 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Drug Discovery, 2022 - 2032F |
6.3.5 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Genetics, 2022 - 2032F |
6.3.6 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By SNP Analysis, 2022 - 2032F |
6.3.7 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Screening and Monitoring Of Patient Data DuringClinical Trials, 2022 - 2032F |
6.3.8 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Other, 2022 - 2032F |
6.3.9 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Other, 2022 - 2032F |
6.4 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Academic and Research Institutes, 2022 - 2032F |
6.4.3 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Biotechnological and Pharmaceutical Companies, 2022 - 2032F |
6.4.4 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Research Laboratories, 2022 - 2032F |
7 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Import-Export Trade Statistics |
7.1 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Export to Major Countries |
7.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Imports from Major Countries |
8 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Key Performance Indicators |
8.1 Number of research collaborations between academic institutions and biotechnology companies in Ireland |
8.2 Percentage increase in government funding for genomics and precision medicine initiatives |
8.3 Adoption rate of DNA and gene chip technology in clinical settings |
8.4 Number of patents filed for new DNA sequencing and microarray technologies |
8.5 Growth in the number of genetic testing facilities and laboratories in Ireland |
9 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Opportunity Assessment |
9.1 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Type, 2022 & 2032F |
9.3 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Competitive Landscape |
10.1 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenue Share, By Companies, 2025 |
10.2 Ireland Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here